First Personal Financial Services Organon & Co. Transaction History

First Personal Financial Services

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$16.59 - $23.77 $348 - $499	-21 Reduced 30.0%	49 $0
Q2 2023 Jul 28, 2023	SELL	$19.27 - $24.63 $520 - $665	-27 Reduced 27.84%	70 $1,000
Q1 2023 Apr 24, 2023	SELL	$21.42 - $32.08 $6,426 - $9,624	-300 Reduced 75.57%	97 $2,000
Q4 2022 Jan 27, 2023	SELL	$23.31 - $28.61 $1,585 - $1,945	-68 Reduced 14.62%	397 $0
Q3 2022 Oct 27, 2022	BUY	$23.4 - $34.25 $6,247 - $9,144	267 Added 134.85%	465 $11,000
Q2 2022 Jul 25, 2022	SELL	$31.66 - $38.9 $1,044 - $1,283	-33 Reduced 14.29%	198 $7,000
Q1 2022 May 02, 2022	SELL	$30.45 - $39.36 $1,218 - $1,574	-40 Reduced 14.76%	231 $8,000
Q4 2021 Feb 04, 2022	SELL	$28.67 - $37.13 $3,755 - $4,864	-131 Reduced 32.59%	271 $8,000
Q3 2021 Nov 04, 2021	SELL	$28.63 - $35.64 $2,863 - $3,564	-100 Reduced 19.92%	402 $13,000
Q2 2021 Aug 02, 2021	BUY	$28.45 - $38.0 $14,281 - $19,076	502 New	502 $15,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.